Effect of 12 Weeks of Zumba Combined With Halotherapy on Body Composition, Respiratory, and Cardiorespiratory Parameters in Sedentary Older Adults

March 13, 2026 updated by: Coşkun YILMAZ, Gümüşhane Universıty
This randomized controlled trial examined the effects of a 12-week Zumba exercise program combined with halotherapy on body composition, aerobic capacity, and physical fitness parameters in adult women. Participants were randomly assigned to a Zumba plus halotherapy group or a control group. Physical fitness tests and body composition measurements were performed before and after the intervention.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Zumba is a popular aerobic dance-based exercise known to improve cardiovascular fitness and body composition. Halotherapy, involving exposure to salt-enriched air, has been suggested to support respiratory function and overall well-being. However, evidence regarding the combined effects of Zumba training and halotherapy is limited.

This study aimed to investigate whether combining halotherapy with regular Zumba training would provide additional benefits compared to no intervention.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Trabzon, Ordu, Giresun, Rize, Artvin, Gümüşhane
      • Gümüşhane, Trabzon, Ordu, Giresun, Rize, Artvin, Gümüşhane, Turkey (Türkiye), 29600
        • Gumushane Univetsity

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Female participants aged [55-80] years
  • Sedentary or recreationally active
  • No regular exercise participation in the previous 6 months

Exclusion Criteria:

  • Cardiovascular, respiratory, or musculoskeletal disorders
  • Pregnancy
  • Participation in structured exercise programs during the study period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Zumba + Halotherapy Group
Participants performed Zumba training sessions [haftada X gün, seans süresi] for 12 weeks. Each session was followed by halotherapy exposure in a salt room environment.
Other: Zumba + Halotherapy Group
Participants performed Zumba training sessions [haftada X gün, seans süresi] for 12 weeks. Each session was followed by halotherapy exposure in a salt room environment.
Other: Control
Participants maintained their usual daily activities without structured exercise or halotherapy.
No Intervention: CONTROL
Participants maintained their usual daily activities without structured exercise or halotherapy.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Composition
Time Frame: 12 week
Parameter: Body weight
12 week
Aerobic Capacity
Time Frame: 12 weeks
Measured by [ 6-minute walk test / VO₂max estimation]
12 weeks
Body Composition
Time Frame: 12 week
Parameter: BMI
12 week

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Handgrip strength
Time Frame: 12 weeks
Test: Handgrip strength
12 weeks
Flexibility
Time Frame: 12 weeks
Test: Sit-and-reach
12 weeks
Balance
Time Frame: 12 weeks
Test: Flamingo or similar balance test
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Gümüşhane Universıty

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 5, 2024

Primary Completion (Actual)

August 15, 2024

Study Completion (Actual)

August 20, 2024

Study Registration Dates

First Submitted

February 6, 2026

First Submitted That Met QC Criteria

February 14, 2026

First Posted (Actual)

February 20, 2026

Study Record Updates

Last Update Posted (Actual)

March 17, 2026

Last Update Submitted That Met QC Criteria

March 13, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2025/0471

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The individual participant data collected in this study will not be shared with other researchers due to the need to protect participant confidentiality and the lack of permission for data sharing within the scope of informed consent.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe